Georgia Micha

Georgia Micha

Auto-generated profile, based on publicly available information

Georgia Micha

Faculty of Medicine, Department of Anesthesiology Ioannina, University of Ioannina, Ipiros, Greece

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2022 in European Journal of Midwifery
Verified
Journal Article
Open access
GMGeorgia Micha
Georgia Micha
THThomas Hyphantis
Thomas Hyphantis
CSChrysoula Staikou
Chrysoula Staikou
DVDimitrios Valsamidis
Dimitrios Valsamidis
Eleni ArnaoutoglouEleni Arnaoutoglou
Eleni Arnaoutoglou
Konstantinos KotsisKonstantinos Kotsis
Konstantinos Kotsis
Introduction: A significant proportion of pregnant women and women in the early postpartum period suffer from mental health problems. The COVID-19 pandemic represents a unique stressor during this period and many studies across the world have shown elevated rates of postpartum depression (PPD)....

10 October 2022 in Cureus
Verified
Journal Article
Open access
GMGeorgia Micha
Georgia Micha
DGDionysios G. Galatis
Dionysios G. Galatis
ASAntonios Strongylos
Antonios Strongylos
CBChristos Benekos
Christos Benekos
KKKONSTANTINA KALOPITA
KONSTANTINA KALOPITA
AMArgyrios Monastiriotis
Argyrios Monastiriotis
Parasitic fibroids are a rare type of extrauterine benign tumors that may be spontaneous or iatrogenic in origin and often difficult to diagnose due to their various presentations. We report an unusual case of a parasitic leiomyoma in a 33-year-old nulliparous woman with remote pelvic history who presented to our institution with sudden-onset lower abdominal pain. We performed an exploratory laparotomy, which revealed a 6.3x4.6 cm mass in the space of the adnexa of the right parametrium. Histopathological examination revealed features compatible with a leiomyoma. It is clear that physicians need to assess clinical findings and imaging techniques in order to establish a correct diagnosis of parasitic myomas, even when a history of myomectomy or a laparoscopic morcellation is absent.

10 September 2009 in European Journal of Pediatric Surgery
Verified
Journal Article
Closed access
GMG. Micha
G. Micha
ESE. Samanta
E. Samanta
DDD. Damigos
D. Damigos
APA. Petridis
A. Petridis
VMV. Mavreas
V. Mavreas
SLS. Livanios
S. Livanios
Background: Ambulatory surgery in children, combined with new anesthetic methods, leads to shorter hospital stays and an increase in patient and parental satisfaction. Aim: Aim of the study was to determine the feasibility and safety of transferring children directly to the ward without a previous stay in a post anesthesia care unit (PACU), after undergoing circumcision for phimosis under regional anesthesia and non-opioid analgesia. Methods: 187 healthy children undergoing circumcision were studied in a randomized manner. After surgery, children who met predefined inclusion criteria in the operating room were randomly assigned to one of two groups. Children in the first group (Group A) bypassed the PACU and were admitted directly to the ward, after undergoing assessment using the White and Song scoring system. Children in the second group (Group B) were first transferred to a PACU and then to the ward. The children in Group A who did not meet the criteria of the White and Song scoring system represent the level of risk associated with direct transfer to the ward and no PACU stay. Recovery in the PACU and the ward, parental satisfaction, number of readmissions and the number of parental contacts for medical problems after discharge were recorded and compared between the two study groups. Results: 157 children were randomly assigned into two groups (79 children in Group A and 78 in Group B). Demographic data, the duration of surgery, and recovery in the PACU or the ward were similar for the two groups. No readmissions were observed and most parents were very satisfied with the procedure. Conclusion: Children undergoing circumcision do not routinely require admission to a PACU and if the appropriate criteria are met, it is safe to transfer them directly to the ward.

5 October 2026 in Rheumatology International
Verified
Journal Article
Open access
PDF file
NZNikolaos Zintziovas
Nikolaos Zintziovas
AKAgathi Karakosta
Agathi Karakosta
PVParaskevi V. Voulgari
Paraskevi V. Voulgari
GSGeorgios Stefanakis
Georgios Stefanakis
Eleni ArnaoutoglouEleni Arnaoutoglou
Eleni Arnaoutoglou
GMGeorgia Micha
Georgia Micha
Persistent pain remains a major unmet need in rheumatoid arthritis (RA), even in patients with adequately controlled inflammatory disease. Cannabinoids have been proposed as potential modulators of pain and inflammation, but their clinical role in RA remains uncertain. To map and critically appraise the available clinical evidence on cannabinoid-related interventions or exposures for pain management in adults with RA. PubMed/MEDLINE, Scopus, the Directory of Open Access Journals, and the Cochrane Central Register of Controlled Trials were searched for studies published from January 1, 1990, to September 10, 2026. Randomized controlled trials and observational studies evaluating cannabinoid-related interventions or exposures in adults with confirmed RA and reporting pain-related outcomes were eligible. Risk of bias was assessed using Cochrane RoB 2 for randomized trials and ROBINS-I for observational studies. Of 593 records identified, three studies met the eligibility criteria: one randomized placebo-controlled trial and two observational studies. In the randomized trial of 58 patients, nabiximols reduced pain on movement by 0.95 points ( p = 0.044), pain at rest by 1.04 points ( p = 0.018), and improved sleep quality by 1.17 points ( p = 0.027); DAS28 decreased by 0.76 points ( p = 0.002), while no serious adverse events were reported. Observational studies suggested possible symptomatic benefit but were limited by heterogeneous cannabinoid exposure and serious to critical risk of bias. Current clinical evidence remains insufficient to establish the efficacy or long-term safety of cannabinoids for RA-related pain. Larger, rigorously designed trials using standardized cannabinoid formulations and pain-relevant outcomes are needed.

7 November 2023 in Indian Journal of Anaesthesia
Verified
Journal Article
Open access
GMGeorgia Micha
Georgia Micha
ESEleftheria Soulioti
Eleftheria Soulioti
AFArgyro Fassoulaki
Argyro Fassoulaki